to the label claim of the marketed tablet formulation followed by subjecting the drug to hydrolysis, oxidation, photolysis and thermal degradation studies. The drug was found to degrade extensively in acidic 0
INTRODUCTION
Sacubitril is a prodrug that is activated to sacubitrilat by de-ethylation via esterases.
Sacubitrilat inhibits the enzyme neprilysin, which is responsible for the degradation of atrial On literature survey, it was found that only RP-HPLC methods [6, 7] was found for the simultaneous estimation of Sacubitril and Valsartan in combined dosage forms and no method is available in the pharmacopoeias. Few analytical methods have been developed for the determination of Sacubitril and Valsartan individually and in combination with other drugs. [8] [9] [10] [11] [12] [13] [14] [15] So we have developed a novel, simple and highly sensitive UV spectrophotometric methods for assay of Sacubitril and valsartan in bulk and pharmaceutical formulations and validated according to ICH guidelines.
MATERIALS AND METHODS

Chemicals and solvents
HPLC grade water and acetonitrile were used for preparing mobile phase. Citric acid (AR grade) were used for preparing the buffer. HCl, NaOH and H 2 O 2 were used for degradation 
HPLC instrumentation and chromatographic conditions
The HPLC system was SPD-20AT, Shimadzu consisting of pump LC-20AT, detector SPD20AT, column EnableC18, 250mm × 4.6mm, 5µ(particle size), thermo scientific, injector rheodyne injector (20 µl capacity) and syringe hamilton (25 µl). Data were processed using chromatographic software Lab Solutions.
A freshly prepared mixture of acetonitrile and citrate buffer (pH 3.0) (60:40v/v) used as the mobile phase. Mobile phase was filtered through a 0.45µm membrane filter and sonicated before use. The flow rate of the mobile phase was maintained at 1.0 ml/min.
Preparation of mobile phase
A 5mM solution of citric acid buffer of pH 3.0 was prepared in 400ml HPLC water. This solution was filtered using a 0.4 µm filter paper. A mixture of HPLC grade acetonitrile and citric acid buffer (pH 3) in the ratio of 60:40 v/v was prepared, sonicated for 20 min, filtered through 0.45 µm membrane filter paper.
Preparation of standard solutions
50 mg of standard SAC and VAL weighed and transferred separately to two different 50 mL volumetric flasks. Both the drugs were dissolved in 25 mL of mobile phase by sonication and then volume was made up to the mark with mobile phase to get a concentration of 1000 µg/mL of each component (stock A solution of both the drugs).
Preparation of sample solutions
Twenty tablets of SAC and VAL in combination were weighed and their average weight was determined. The tablets were crushed to fine powder and a tablet powder equivalent to 100 mg of each SAC and VAL was weighed and transferred to 100 mL volumetric flask, dissolved in sufficient quantity of mobile phase. The solution was filtered through 0.4 µm membrane filter paper. The contents were sonicated for 20 minutes and the final volume was made up to the mark with mobile phase (sample stock 'A' solution).
Appropriate aliquots were pipetted out from the sample stock 'A' solution (1000 µg/mL) in to a series of 10 mL volumetric flasks. The volume was made up to the mark with the mobile phase to get a set of solutions having the concentration range of 20, 40, 80, 160 and 320 µg/mL for both SAC and VAL.
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Selection of analytical wavelength
The standard solution of SAC (80 µg/ml) and VAL (80 µg/ml) were scanned in the UV region of 200-400 nm using methanol as a blank and the overlain spectra was recorded.
270nm analytical wavelength was selected for estimation of SAC and VAL.
Optimization of HPLC method
The pure drug solutions of SAC (80 µg/ml) and VAL (80 µg/ml) were injected individually into HPLC system and allow to run in different mobile phases like methanol, water: methanol, water: acetonitrile, phosphate buffer: methanol and phosphate buffer: acetonitrile were tried in order to find the optimum conditions for the separation of SAC and VAL. It was found that mobile phase containing acetonitrile and citrate buffer (pH 3.0) (60:40v/v) at a flow rate of 1.0 ml/min with detection wavelength 267 nm gave satisfactory results with sharp, well defined and resolved peaks with minimum tailing as compared to other mobile phases. Under these conditions the retention times were typically 4.882 min for SAC and 5.540 min for VAL ( Fig. 3 ) and optimized chromatographic conditions described in (Table   1 ). 
HPLC Method Validation
The developed HPLC method was validated as per ICH guidelines for following parameters Linearity, Limit of Detection, Limit of Quantification, Accuracy, Precision, Robustness.
Forced degradation studies
The study was intended to ensure the effective separation of SAC, VAL and its degradation peaks of formulation ingredients at the retention time of SAC and VAL. Forced degradation studies were performed to evaluate the stability indicating properties and specificity of the methods. 1 N NaOH and solution was diluted up to 10 ml with mobile phase. Dilution was done to achieve the appropriate concentration 65 µg/ml of SAC and 5 µg/ml of VAL. Result is shown in (Fig. 4) .
Acid degradation
Fig. 8: Chromatogram of combined SAC and VAL mixture in acid degradation
Alkaline degradation
Forced degradation in basic media was performed by keeping the standard solution in contact with 0.1 N NaOH for 1 hr at room temperature. After 1 hr the solution was neutralized with 0.1 N HCland solution was diluted upto 10 ml with mobile phase. Dilution was done to achieve the appropriate concentration 65 µg/ml of PCM and 5 µg/ml of PAM. Result is shown in (Fig. 5) . 
Oxidation degradation
Forced degradation in 3% H2O2 media was performed by keeping the standard solution in contact with 3% H2O2 for 1 hr at room temperature. After 1 hr, solution was diluted with mobile phase up to 10 ml to achieve the appropriate concentration 65 µg/ml of PCM and 5 µg/ml of PAM. Result is shown in (Fig. 6 ).
Fig. 10: Chromatogram of combined SAC and VAL mixture in oxidative degradation
Thermal degradation
Sample solution was exposed to temperature of 105°c for half an hour in an oven. After half an hour, solution was diluted with mobile phase up to 10 ml. From this solution, dilution was done to achieve the appropriate conc. 65 µg/ml of PCM and 5 µg/ml of PAM. Result is shown in (Fig. 7) . 
Photolytic degradation
Sample solution was exposed in the sunlight for 2 hrs. After 2 hrs. solution was diluted with mobile phase up to 10 ml. From this solution, dilution was done to achieve the appropriate concentration 65 µg/ml of PCM and 5 µg/ml of PAM. Result is shown in (Fig. 8) .
Fig. 12: Chromatogram of combined SAC and VAL mixture in photolytic degradation
RESULTS AND DISCUSSION
The present manuscript deals with simultaneous estimation of SAC and VAL in combined tablet dosage form by RP-HPLC method using mobile phase as the solvent. The developed method is based upon estimation of both the drugs by determining the area under curve of the chromatogram at selected analytical wavelength. The linearity of the proposed method was established by least square regression analysis of the calibration curve The drug response was linear (R 2 = 0.9999 for SAC and 0.9999 for VAL) over the concentration ranges between 20-320 µg/ml for both SAC and VAL as shown in the Table 9 .
Recovery studies were also performed to determine the accuracy and precision of the proposed method. Recovery experiments were performed at three levels, 80%, 100% and 120% of the labeled amount of both the drugs (80 mg SAC and VAL each) in tablet formulation as shown in Table 1 . Three replicate samples of each concentration levels were prepared and the percentage recovery at each level (n = 3) and mean % recovery (n = 3) were determined and summarized in Table 1 Inter-day precision was evaluated by analyzing a set of quality control samples of the tablet formulation containing 80 µg/ml of SAC and VAL each, three levels analysed on three consecutive days. The statistical validation data for inter-day precision is summarized in Table 5 . Both intra-day and inter-day variation showed less % RSD value indicating high grade of precision of the method as shown in Table 11 respectively. The results of the methods lie within the prescribed limit, showing that method is free from interference from excipients The validation results obtained confirm the suitability of the proposed stability indicating RP-HPLC method for simple, accurate and precise analysis of SAC and VAL in pharmaceutical preparations. The proposed method does not need prior separation of SAC and VAL before analysis. In addition, it is suitable for application without interference of excipients and can be applied directly to the commercial preparation without previous treatment. Where n *= 3.
Level of % recovery
Amount present (µg/mL) Where n *= 3. 
